LEADERSHIP TEAM PROFILES
Our leadership team is proud to uphold the core values, vision and mission for Alexium associates and our investors.
DR. ROBERT BROOKINS
Chief Executive Officer
Robert (Bob) Brookins, Ph.D., M.A.E. B.A. B.Sc is the Chief Executive Officer. Dr. Brookins has experience in organic synthesis, materials chemistry, and chem/bio decontamination. He received his Ph.D. from the University of Florida in the areas of synthesis and characterization of conjugated poly-electrolytes and polymers with an emphasis on developing new polymerization methods. Upon completion of his Ph.D., he worked at the US Air Force Research Laboratory at Tyndall AFB, FL where he developed decontamination methods for chemical and biological threats and developed novel synthetic routes for reactive and functional surfaces.
Chief Financial Officer
Over the past 22 years, Jason Lewis has worked with ArrMaz, a global specialty chemical company in mining, fertilizer, phosphate, asphalt and oil and gas industries. For the past six years, Lewis has held the position of Vice President of Finance. He joined the company in a senior accounting role with cross-departmental work for sales, marketing and operations groups for seven years. Lewis has a strong track record of value creation by way of revenue growth through pricing, long-term customer contracts, cost optimization through analysis tools, negotiation of services, department restructuring, debt management and working capital reduction through controls and process improvements. He also has strong international experience including greenfield start-ups.
Chief Commercial Officer
Prior to joining Alexium, Allen Reihman worked for nine years at Invista, the world’s largest integrated fiber, resin, and intermediates company. As Director of New Business Development, Reihman was the entrepreneur for the successful commercialization of new specialty polymers. He led all phases of this innovation program, including product development, manufacturing, intellectual property, pricing strategies, branding, business planning, and strategic alliances. Additionally, Reihman served as Director of Commercial Development for five global specialty chemical businesses at Invista where he led growth initiatives, valuation and decision analysis, market research, and strategy development. Previously, Reihman worked for seven years at Eastman Chemical where he held a range of commercial leadership roles in corporate development, global P&L general management, innovation, and market development.
BOARD OF DIRECTORS
Rosheen Garnon (BEc (Accounting major), LLB, FCA, CTA, GAICD) has had a distinguished career in the accounting profession as a chartered accountant and taxation advisor. She was a senior partner with KPMG and held senior executive leadership roles with the Firm in Australia and at a global level. Garnon was a member of the KPMG Australian Executive Leadership Team for six years as the National Managing Partner for a significant client services division. She has extensive experience of working with Boards and C-Suite executives.
Garnon started her career with Peat Marwick Mitchell & Co (a predecessor firm of KPMG) in 1987 and was made partner in July 2000. She has extensive experience working with multinational organisations particularly in the mining, oil &gas, and defense industries. Garnon’s prominence in the accounting profession was recently recognized in her appointment to the Board of Taxation, an Independent Advisory Board, that advises the Federal Treasurer and Assistant Treasurer on Australia’s Taxation Policy.
BRIG. GEN. STEPHEN CHENEY, USMC (RET).
General Stephen Cheney was a decorated Marine and is the former Inspector General of the Marine Corps and Commanding General of Parris Island Marine Base. He was appointed on April 15, 2015 to Alexium’s board. He is also the former Deputy Executive Secretary to U.S. Defense Secretary Dick Cheney and was also a member of Secretary of State John Kerry’s Foreign Affairs Policy Board. General Cheney serves as the chairman of Alexium’s Remuneration Committee.
Simon Moore, a Senior Partner of Colinton Capital Partners, has been appointed as non-executive director. Mr. Moore has over 20 years of experience in senior private equity roles including previously acting as Managing Director and Global Partner of the Carlyle Group. He currently serves on several boards in the roles of Director at First Wave Cloud Technologies, Director at Guzman y Gomez, Director at TPI Enterprises, and Director at Megaport.
DR PAUL STENSON
Dr. Paul Stenson BSc (Science), PhD (Chemistry) has had a distinguished career with the research, development, manufacture, and commercialization of new materials. Dr. Stenson is currently President and CEO of StanChem Inc., comprising of two companies – StanChem Polymers, and Albi Protective Coatings. Dr Stenson has over 20 years of experience in senior management positions in the polymer and chemicals industry. Dr. Stenson is also the chairman of TopChem Pharmaceuticals (Ireland) which is a manufacturer of active pharmaceutical ingredients.